Document is current
Any future updates will be listed below
-
Authors
Yang, Nan http://orcid.org/0000-0002-6509-6328
Singhera, Gurpreet K.
Yan, Yi Xuan
Pieper, Michael P.
Leung, Janice M.
Sin, Don D.
Dorscheid, Delbert R.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (20R25167)
Michael Smith Foundation for Health Research (NJZY 20R7746)
AllerGen (NMJK 20R12545)
British Columbia Lung Association (NRLQ 20R00475)
Canada Research Chairs
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 10 April 2020
Accepted: 10 February 2021
First Online: 23 February 2021
Ethics approval and consent to participate
: All experiments in this study were approved by the Research Ethics Board of University of British Columbia/Providence Healthcare (REB# H11-02713 and REB# H15-01778).
: Not applicable.
: MP is an employee of Boehringer Ingelheim, which supported this study. DS has received honoraria for speaking engagements from Astrazeneca, Boehringer Ingelheim and Novartis and received research funding from Astrazeneca, Boehringer Ingelheim and Merck. The other authors declare no relevant conflicts of interest.
